DOI: 10.1055/s-00000007

Aktuelle Urologie

References

Bellmunt J. et al.
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.

N Engl J Med 2017;
376: 1015-1026

Download Bibliographical Data

Access:
Access: